Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-536-5 | CAS number: 107-95-9
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 23.509 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 33.333 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
Workers - Hazard for the eyes
Additional information - workers
In general, the calculation of DNEL is based on the observed effect level which has to be modified as described in the ECHA guidance document "Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health", May 2008
The DNEL is calculated according to the general formula:
Corrected starting point: NOAEL/AF
Using the no-adverse effect level of oral study (NOAEL = 1000 mg/kg/day, 28-day, oral gavage study), the corrected starting point (NAEC) for the inhalative route is calculated according following formula for worker: = NOAEL* 1/0.38*6.7/10, where 6.7/10 mg/m³ represents the human light activity and 0.38 m³/kg is the standard breathing volume for the rats for 8 hours exposure for workers.
Using the no-adverse effect level of oral study (NOAEL= 1000 mg/kg/day, 28 -day, oral gavage study), the correct starting point (NAEL) for the dermal route is calculated taking in consideration the absorption difference (0.1), being the dermal absorption (calculated with DERMWIN Skin Permeability Model) of β-alanine very low (Dermal Absorption 0.00029 mg/cm²/h; absorption potential: 10%).
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.797 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 16.667 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.667 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
In general, the calculation of DNEL is based on the observed effect level which has to be modified as described in the ECHA guidance document "Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health", May 2008
The DNEL is calculated according to the general formula:
Corrected starting point: NOAEL/AF
Using the no-adverse effect level of oral study (NOAEL= 1000 mg/kg/day, 28-day, oral gavage study), the corrected starting point for the inhalative route (NAEL) is calculated according following formula for general population: = NOAEL* 1/1.15, where 1.15 m³/kg is the standard breathing volume for rat for 24 hours exposure of general public.
Using the no-adverse effect level of oral study (NOAEL= 1000 mg/kg/day, 28-day, oral gavage study), the correct starting point for the dermal route (NAEL) is calculated taking in consideration the absorption difference (0.1), being the dermal absorption (calculated with DERMWIN Skin Permeability Model) of beta-alanine very low (Dermal Absorption 0.00029 mg/cm²/h; absorption potential: 10%).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
